A recently concluded cooperative R&D project at the FDA led to the development of a web-enabled software tool that will be useful for modeling the impact of predictive biomarkers on the complexity and cost of clinical development programs.
Hear from the project's FDA Principal Investigator and from Adaptive Pharmacogenomic's PI on the project in a pair of webinars, August 24 and 25.
In the two complementary webinars learn about the U.S. Food and Drug Administration (FDA)-Adaptive Pharmacogenomics (APG) software tool for modeling clinical development strategies that include predictive biomarkers. The webinars will relate experiences with the tool in the FDA's Genomics Group, Office of Clinical Pharmacology. The Tuesday, August 24 webinar will feature the history, motivation, and use of the FDA-APG tool with reference to specific hypothetical case studies from the Genomics Group. The Wednesday, August 25 webinar will feature the specific, measurable inputs and outputs to use in strategy selection identified in the FDA-APG collaboration and the methodology for how to collect and organize this knowledge. At the end of the webinars on August 25, you'll understand what the software does, how to use it, and the experiences of the Genomics Group. Each webinar will end with a question and answer period. You may register for one or both webinars.
Dates, times, presenters for the webinars:
Tuesday, August 24 at 11:30 a.m.- 1:00 p.m. Eastern time. Federico Goodsaid and Michael Palmer will present.
Wednesday, August 25 at 11:30 a.m. - 1:00 pm Eastern time. Michael Palmer will present.
Download the detailed webinar announcement here:
http://www.adaptivepharmacogenomics.com/users/CRADAtoolWebinarsAugust2010APG.pdf